nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Conjunctival oedema—Carmustine—malignant glioma	0.0788	0.0827	CcSEcCtD
Apraclonidine—Hyperaemia—Carmustine—malignant glioma	0.0724	0.076	CcSEcCtD
Apraclonidine—Visual acuity reduced—Temozolomide—malignant glioma	0.0355	0.0373	CcSEcCtD
Apraclonidine—Parosmia—Temozolomide—malignant glioma	0.0326	0.0342	CcSEcCtD
Apraclonidine—Coordination abnormal—Carmustine—malignant glioma	0.0223	0.0234	CcSEcCtD
Apraclonidine—Coordination abnormal—Temozolomide—malignant glioma	0.0215	0.0226	CcSEcCtD
Apraclonidine—Dry eye—Temozolomide—malignant glioma	0.0195	0.0205	CcSEcCtD
Apraclonidine—Abnormal vision—Carmustine—malignant glioma	0.0191	0.02	CcSEcCtD
Apraclonidine—Abnormal vision—Temozolomide—malignant glioma	0.0184	0.0193	CcSEcCtD
Apraclonidine—Eye pain—Carmustine—malignant glioma	0.0176	0.0185	CcSEcCtD
Apraclonidine—Eye pain—Temozolomide—malignant glioma	0.017	0.0178	CcSEcCtD
Apraclonidine—Face oedema—Carmustine—malignant glioma	0.0153	0.0161	CcSEcCtD
Apraclonidine—Face oedema—Temozolomide—malignant glioma	0.0148	0.0155	CcSEcCtD
Apraclonidine—Infestation NOS—Temozolomide—malignant glioma	0.0118	0.0124	CcSEcCtD
Apraclonidine—Infestation—Temozolomide—malignant glioma	0.0118	0.0124	CcSEcCtD
Apraclonidine—Haemorrhage—Carmustine—malignant glioma	0.011	0.0115	CcSEcCtD
Apraclonidine—Oedema peripheral—Carmustine—malignant glioma	0.0108	0.0114	CcSEcCtD
Apraclonidine—Haemorrhage—Temozolomide—malignant glioma	0.0106	0.0111	CcSEcCtD
Apraclonidine—Visual impairment—Carmustine—malignant glioma	0.0106	0.0111	CcSEcCtD
Apraclonidine—Pharyngitis—Temozolomide—malignant glioma	0.0105	0.0111	CcSEcCtD
Apraclonidine—Oedema peripheral—Temozolomide—malignant glioma	0.0105	0.011	CcSEcCtD
Apraclonidine—Eye disorder—Carmustine—malignant glioma	0.0103	0.0108	CcSEcCtD
Apraclonidine—Visual impairment—Temozolomide—malignant glioma	0.0102	0.0107	CcSEcCtD
Apraclonidine—Eye disorder—Temozolomide—malignant glioma	0.00992	0.0104	CcSEcCtD
Apraclonidine—Arrhythmia—Carmustine—malignant glioma	0.00981	0.0103	CcSEcCtD
Apraclonidine—Angiopathy—Temozolomide—malignant glioma	0.00963	0.0101	CcSEcCtD
Apraclonidine—Mental disorder—Carmustine—malignant glioma	0.00962	0.0101	CcSEcCtD
Apraclonidine—Mediastinal disorder—Temozolomide—malignant glioma	0.00956	0.01	CcSEcCtD
Apraclonidine—Erythema—Carmustine—malignant glioma	0.00956	0.01	CcSEcCtD
Apraclonidine—Mental disorder—Temozolomide—malignant glioma	0.0093	0.00976	CcSEcCtD
Apraclonidine—Erythema—Temozolomide—malignant glioma	0.00924	0.0097	CcSEcCtD
Apraclonidine—Dysgeusia—Temozolomide—malignant glioma	0.00905	0.00949	CcSEcCtD
Apraclonidine—Vision blurred—Carmustine—malignant glioma	0.00901	0.00946	CcSEcCtD
Apraclonidine—Vision blurred—Temozolomide—malignant glioma	0.00871	0.00914	CcSEcCtD
Apraclonidine—Ill-defined disorder—Temozolomide—malignant glioma	0.00857	0.009	CcSEcCtD
Apraclonidine—Malaise—Temozolomide—malignant glioma	0.00833	0.00874	CcSEcCtD
Apraclonidine—Palpitations—Temozolomide—malignant glioma	0.00816	0.00857	CcSEcCtD
Apraclonidine—Chest pain—Carmustine—malignant glioma	0.00814	0.00854	CcSEcCtD
Apraclonidine—Myalgia—Carmustine—malignant glioma	0.00814	0.00854	CcSEcCtD
Apraclonidine—Myalgia—Temozolomide—malignant glioma	0.00786	0.00825	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00781	0.0082	CcSEcCtD
Apraclonidine—Oedema—Carmustine—malignant glioma	0.0078	0.00819	CcSEcCtD
Apraclonidine—Discomfort—Temozolomide—malignant glioma	0.00777	0.00816	CcSEcCtD
Apraclonidine—Infection—Carmustine—malignant glioma	0.00775	0.00813	CcSEcCtD
Apraclonidine—Dry mouth—Temozolomide—malignant glioma	0.00769	0.00807	CcSEcCtD
Apraclonidine—Oedema—Temozolomide—malignant glioma	0.00754	0.00791	CcSEcCtD
Apraclonidine—Infection—Temozolomide—malignant glioma	0.00749	0.00786	CcSEcCtD
Apraclonidine—Nervous system disorder—Temozolomide—malignant glioma	0.00739	0.00776	CcSEcCtD
Apraclonidine—Skin disorder—Temozolomide—malignant glioma	0.00732	0.00769	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00711	0.00746	CcSEcCtD
Apraclonidine—Insomnia—Carmustine—malignant glioma	0.00706	0.00741	CcSEcCtD
Apraclonidine—Paraesthesia—Carmustine—malignant glioma	0.007	0.00735	CcSEcCtD
Apraclonidine—Dyspnoea—Carmustine—malignant glioma	0.00695	0.0073	CcSEcCtD
Apraclonidine—Somnolence—Carmustine—malignant glioma	0.00694	0.00728	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00687	0.00721	CcSEcCtD
Apraclonidine—Insomnia—Temozolomide—malignant glioma	0.00682	0.00716	CcSEcCtD
Apraclonidine—Paraesthesia—Temozolomide—malignant glioma	0.00677	0.00711	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00673	0.00707	CcSEcCtD
Apraclonidine—Dyspnoea—Temozolomide—malignant glioma	0.00672	0.00705	CcSEcCtD
Apraclonidine—Somnolence—Temozolomide—malignant glioma	0.0067	0.00703	CcSEcCtD
Apraclonidine—Pain—Carmustine—malignant glioma	0.00667	0.007	CcSEcCtD
Apraclonidine—Constipation—Carmustine—malignant glioma	0.00667	0.007	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00651	0.00683	CcSEcCtD
Apraclonidine—Fatigue—Temozolomide—malignant glioma	0.0065	0.00682	CcSEcCtD
Apraclonidine—Pain—Temozolomide—malignant glioma	0.00645	0.00677	CcSEcCtD
Apraclonidine—Constipation—Temozolomide—malignant glioma	0.00645	0.00677	CcSEcCtD
Apraclonidine—Feeling abnormal—Carmustine—malignant glioma	0.00643	0.00675	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Carmustine—malignant glioma	0.00638	0.0067	CcSEcCtD
Apraclonidine—Feeling abnormal—Temozolomide—malignant glioma	0.00621	0.00652	CcSEcCtD
Apraclonidine—Abdominal pain—Carmustine—malignant glioma	0.00617	0.00647	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00616	0.00647	CcSEcCtD
Apraclonidine—Abdominal pain—Temozolomide—malignant glioma	0.00596	0.00626	CcSEcCtD
Apraclonidine—Hypersensitivity—Carmustine—malignant glioma	0.00575	0.00603	CcSEcCtD
Apraclonidine—Asthenia—Carmustine—malignant glioma	0.0056	0.00587	CcSEcCtD
Apraclonidine—Hypersensitivity—Temozolomide—malignant glioma	0.00555	0.00583	CcSEcCtD
Apraclonidine—Asthenia—Temozolomide—malignant glioma	0.00541	0.00568	CcSEcCtD
Apraclonidine—Diarrhoea—Carmustine—malignant glioma	0.00534	0.0056	CcSEcCtD
Apraclonidine—Pruritus—Temozolomide—malignant glioma	0.00533	0.0056	CcSEcCtD
Apraclonidine—Dizziness—Carmustine—malignant glioma	0.00516	0.00541	CcSEcCtD
Apraclonidine—Diarrhoea—Temozolomide—malignant glioma	0.00516	0.00541	CcSEcCtD
Apraclonidine—Dizziness—Temozolomide—malignant glioma	0.00499	0.00523	CcSEcCtD
Apraclonidine—Vomiting—Carmustine—malignant glioma	0.00496	0.00521	CcSEcCtD
Apraclonidine—Dermatitis—Carmustine—malignant glioma	0.00491	0.00516	CcSEcCtD
Apraclonidine—Headache—Carmustine—malignant glioma	0.00489	0.00513	CcSEcCtD
Apraclonidine—Vomiting—Temozolomide—malignant glioma	0.00479	0.00503	CcSEcCtD
Apraclonidine—Dermatitis—Temozolomide—malignant glioma	0.00475	0.00498	CcSEcCtD
Apraclonidine—Headache—Temozolomide—malignant glioma	0.00472	0.00496	CcSEcCtD
Apraclonidine—Nausea—Carmustine—malignant glioma	0.00463	0.00486	CcSEcCtD
Apraclonidine—Nausea—Temozolomide—malignant glioma	0.00448	0.0047	CcSEcCtD
Apraclonidine—ADRA2A—Metabolism—CAT—malignant glioma	2.7e-05	0.000572	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PDGFRA—malignant glioma	2.7e-05	0.00057	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PTK2—malignant glioma	2.69e-05	0.000569	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—PIK3CA—malignant glioma	2.69e-05	0.000569	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PIK3CG—malignant glioma	2.68e-05	0.000568	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCL8—malignant glioma	2.68e-05	0.000567	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HES1—malignant glioma	2.64e-05	0.000559	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—AKT2—malignant glioma	2.64e-05	0.000559	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PTPN11—malignant glioma	2.64e-05	0.000558	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NTRK1—malignant glioma	2.63e-05	0.000556	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NCOR1—malignant glioma	2.63e-05	0.000556	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NOTCH2—malignant glioma	2.62e-05	0.000554	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SPP1—malignant glioma	2.62e-05	0.000553	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCL8—malignant glioma	2.61e-05	0.000551	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—TP53—malignant glioma	2.6e-05	0.00055	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—PIK3CD—malignant glioma	2.6e-05	0.000549	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—RAF1—malignant glioma	2.59e-05	0.000548	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—KNG1—malignant glioma	2.56e-05	0.000542	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CAV1—malignant glioma	2.56e-05	0.000542	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—IL2—malignant glioma	2.56e-05	0.000542	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—NCOR1—malignant glioma	2.55e-05	0.00054	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—PIK3CD—malignant glioma	2.54e-05	0.000537	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—PIK3CB—malignant glioma	2.53e-05	0.000535	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PDGFRA—malignant glioma	2.52e-05	0.000532	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL2—malignant glioma	2.49e-05	0.000526	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TERT—malignant glioma	2.48e-05	0.000525	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—AKT2—malignant glioma	2.46e-05	0.000519	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MMP3—malignant glioma	2.45e-05	0.000517	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SPP1—malignant glioma	2.44e-05	0.000517	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NTRK1—malignant glioma	2.44e-05	0.000517	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—PIK3CB—malignant glioma	2.44e-05	0.000515	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCL8—malignant glioma	2.43e-05	0.000515	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CDKN2B—malignant glioma	2.42e-05	0.000512	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PDGFB—malignant glioma	2.42e-05	0.000512	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—FGFR1—malignant glioma	2.41e-05	0.000509	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—KRAS—malignant glioma	2.38e-05	0.000503	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HIF1A—malignant glioma	2.37e-05	0.000502	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PIK3CD—malignant glioma	2.36e-05	0.000499	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PTK2—malignant glioma	2.35e-05	0.000498	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—AKT1—malignant glioma	2.35e-05	0.000497	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	2.34e-05	0.000495	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PIK3CG—malignant glioma	2.34e-05	0.000494	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL2—malignant glioma	2.33e-05	0.000492	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TERT—malignant glioma	2.32e-05	0.00049	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HES1—malignant glioma	2.31e-05	0.000489	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	2.3e-05	0.000486	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CAV1—malignant glioma	2.29e-05	0.000485	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MMP3—malignant glioma	2.27e-05	0.00048	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—KDR—malignant glioma	2.27e-05	0.00048	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	2.27e-05	0.000479	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—PIK3CB—malignant glioma	2.27e-05	0.000479	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PDGFB—malignant glioma	2.26e-05	0.000478	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PPARG—malignant glioma	2.25e-05	0.000476	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CDKN2B—malignant glioma	2.25e-05	0.000476	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—FGFR1—malignant glioma	2.25e-05	0.000476	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	2.24e-05	0.000473	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HIF1A—malignant glioma	2.22e-05	0.000469	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	2.21e-05	0.000468	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	2.2e-05	0.000465	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—AKT1—malignant glioma	2.2e-05	0.000465	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PTK2—malignant glioma	2.19e-05	0.000462	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—PIK3CA—malignant glioma	2.19e-05	0.000462	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—F2—malignant glioma	2.18e-05	0.000462	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—FN1—malignant glioma	2.18e-05	0.000462	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCL8—malignant glioma	2.18e-05	0.00046	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—BAD—malignant glioma	2.16e-05	0.000456	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HES1—malignant glioma	2.15e-05	0.000454	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CAV1—malignant glioma	2.14e-05	0.000453	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NOTCH1—malignant glioma	2.14e-05	0.000452	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SPP1—malignant glioma	2.14e-05	0.000452	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NCOR1—malignant glioma	2.14e-05	0.000452	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	2.13e-05	0.00045	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—KDR—malignant glioma	2.12e-05	0.000448	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—TP53—malignant glioma	2.11e-05	0.000447	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—RAF1—malignant glioma	2.11e-05	0.000445	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CD80—malignant glioma	2.09e-05	0.000443	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—APC—malignant glioma	2.09e-05	0.000442	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PIK3CG—malignant glioma	2.09e-05	0.000442	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CAV1—malignant glioma	2.08e-05	0.00044	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2—malignant glioma	2.08e-05	0.00044	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—EGF—malignant glioma	2.07e-05	0.000437	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PIK3CB—malignant glioma	2.06e-05	0.000435	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PTPN11—malignant glioma	2.05e-05	0.000434	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PIK3CD—malignant glioma	2.05e-05	0.000434	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PDGFRA—malignant glioma	2.05e-05	0.000432	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—F2—malignant glioma	2.04e-05	0.000431	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—FN1—malignant glioma	2.04e-05	0.000431	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2—malignant glioma	2.03e-05	0.00043	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TERT—malignant glioma	2.03e-05	0.000428	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—BAD—malignant glioma	2.02e-05	0.000426	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NOTCH1—malignant glioma	2e-05	0.000422	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SPP1—malignant glioma	1.99e-05	0.00042	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	1.98e-05	0.000418	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	1.98e-05	0.000418	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	1.97e-05	0.000416	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—BRAF—malignant glioma	1.96e-05	0.000415	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CD80—malignant glioma	1.96e-05	0.000414	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—APC—malignant glioma	1.95e-05	0.000413	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PIK3CG—malignant glioma	1.95e-05	0.000413	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	1.94e-05	0.00041	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—EGF—malignant glioma	1.93e-05	0.000408	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PTPN11—malignant glioma	1.92e-05	0.000406	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—AKT2—malignant glioma	1.91e-05	0.000404	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—EGFR—malignant glioma	1.9e-05	0.000403	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PIK3CG—malignant glioma	1.9e-05	0.000401	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2—malignant glioma	1.89e-05	0.000399	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TERT—malignant glioma	1.88e-05	0.000398	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CAV1—malignant glioma	1.87e-05	0.000396	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—KDR—malignant glioma	1.85e-05	0.000392	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	1.84e-05	0.000388	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	1.84e-05	0.000388	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—BRAF—malignant glioma	1.84e-05	0.000388	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PPARG—malignant glioma	1.83e-05	0.000387	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	1.83e-05	0.000386	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	1.82e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	1.8e-05	0.000381	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	1.8e-05	0.00038	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PIK3CB—malignant glioma	1.79e-05	0.000378	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—AKT2—malignant glioma	1.79e-05	0.000378	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—AKT1—malignant glioma	1.79e-05	0.000377	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—FN1—malignant glioma	1.78e-05	0.000377	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—F2—malignant glioma	1.78e-05	0.000377	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—EGFR—malignant glioma	1.78e-05	0.000376	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PTGS2—malignant glioma	1.77e-05	0.000375	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—BAD—malignant glioma	1.76e-05	0.000373	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—FGF2—malignant glioma	1.76e-05	0.000372	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	1.75e-05	0.000369	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CAV1—malignant glioma	1.74e-05	0.000368	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—KDR—malignant glioma	1.72e-05	0.000364	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PIK3CD—malignant glioma	1.72e-05	0.000363	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CD80—malignant glioma	1.71e-05	0.000362	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	1.71e-05	0.000361	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—APC—malignant glioma	1.71e-05	0.000361	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—PIK3CA—malignant glioma	1.7e-05	0.000359	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EGF—malignant glioma	1.69e-05	0.000357	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—KRAS—malignant glioma	1.68e-05	0.000355	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	1.68e-05	0.000355	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PIK3CD—malignant glioma	1.67e-05	0.000353	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—F2—malignant glioma	1.66e-05	0.00035	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—FN1—malignant glioma	1.66e-05	0.00035	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	1.65e-05	0.000349	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MDM2—malignant glioma	1.65e-05	0.000348	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—FGF2—malignant glioma	1.64e-05	0.000347	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—RAF1—malignant glioma	1.64e-05	0.000347	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—BAD—malignant glioma	1.64e-05	0.000346	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	1.62e-05	0.000343	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	1.62e-05	0.000343	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—BRAF—malignant glioma	1.6e-05	0.000339	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	1.6e-05	0.000339	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CD80—malignant glioma	1.59e-05	0.000336	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—APC—malignant glioma	1.59e-05	0.000335	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	1.59e-05	0.000335	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EGF—malignant glioma	1.57e-05	0.000331	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—AKT2—malignant glioma	1.56e-05	0.00033	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	1.56e-05	0.000329	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	1.56e-05	0.000329	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PTEN—malignant glioma	1.55e-05	0.000327	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	1.54e-05	0.000326	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	1.54e-05	0.000325	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MDM2—malignant glioma	1.54e-05	0.000325	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—RAF1—malignant glioma	1.53e-05	0.000324	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	1.52e-05	0.000321	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	1.5e-05	0.000317	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	1.5e-05	0.000316	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—BRAF—malignant glioma	1.49e-05	0.000315	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	1.49e-05	0.000314	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	1.49e-05	0.000314	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CASP3—malignant glioma	1.47e-05	0.000311	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2—malignant glioma	1.47e-05	0.000311	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	1.47e-05	0.000311	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PIK3CB—malignant glioma	1.45e-05	0.000307	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—AKT2—malignant glioma	1.45e-05	0.000307	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	1.44e-05	0.000305	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PTGS2—malignant glioma	1.44e-05	0.000304	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	1.44e-05	0.000304	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	1.44e-05	0.000304	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	1.39e-05	0.000295	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MMP9—malignant glioma	1.39e-05	0.000294	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	1.39e-05	0.000294	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PTEN—malignant glioma	1.38e-05	0.000293	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	1.38e-05	0.000292	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CASP3—malignant glioma	1.38e-05	0.000291	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2—malignant glioma	1.37e-05	0.00029	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	1.37e-05	0.000289	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	1.35e-05	0.000285	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	1.35e-05	0.000285	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	1.34e-05	0.000284	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	1.34e-05	0.000283	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	1.33e-05	0.000282	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	1.33e-05	0.00028	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	1.31e-05	0.000277	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	1.3e-05	0.000275	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	1.29e-05	0.000273	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	1.26e-05	0.000267	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.26e-05	0.000266	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PTEN—malignant glioma	1.26e-05	0.000266	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.25e-05	0.000265	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	1.25e-05	0.000264	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1.25e-05	0.000264	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1.24e-05	0.000263	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	1.24e-05	0.000262	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	1.23e-05	0.00026	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	1.22e-05	0.000257	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.21e-05	0.000257	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1.2e-05	0.000254	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2—malignant glioma	1.2e-05	0.000254	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	1.17e-05	0.000247	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	1.17e-05	0.000247	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	1.16e-05	0.000244	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—MYC—malignant glioma	1.15e-05	0.000243	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	1.14e-05	0.00024	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	1.13e-05	0.000239	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.13e-05	0.000239	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	1.13e-05	0.000238	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.12e-05	0.000236	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.12e-05	0.000236	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	1.1e-05	0.000233	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—PIK3CA—malignant glioma	1.09e-05	0.000231	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—MYC—malignant glioma	1.07e-05	0.000227	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	1.06e-05	0.000225	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.06e-05	0.000223	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	1.05e-05	0.000222	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.05e-05	0.000222	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.02e-05	0.000217	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	1.02e-05	0.000216	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	1.01e-05	0.000214	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	9.93e-06	0.00021	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	9.76e-06	0.000206	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	9.49e-06	0.000201	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TP53—malignant glioma	9.45e-06	0.0002	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—MYC—malignant glioma	9.39e-06	0.000199	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	9.39e-06	0.000199	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	9.19e-06	0.000194	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	9.12e-06	0.000193	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—AKT1—malignant glioma	8.91e-06	0.000188	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—PIK3CA—malignant glioma	8.86e-06	0.000187	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TP53—malignant glioma	8.82e-06	0.000187	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—MYC—malignant glioma	8.73e-06	0.000184	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	8.68e-06	0.000183	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	8.54e-06	0.00018	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	8.06e-06	0.00017	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	7.98e-06	0.000169	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	7.97e-06	0.000169	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TP53—malignant glioma	7.71e-06	0.000163	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	7.45e-06	0.000158	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	7.41e-06	0.000157	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—AKT1—malignant glioma	7.24e-06	0.000153	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TP53—malignant glioma	7.17e-06	0.000152	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	6.51e-06	0.000138	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	6.05e-06	0.000128	CbGpPWpGaD
